Vidofludimus
-
Catalog numberB1633-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameVidofludimus; 4SC-101; 4SC 101; 4SC101; SC12267; SC 12267, SC-12267; 2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid
-
DescriptionVidofludimus is a novel immunosuppressive drug that inhibits DHODH; inhibits IL-17 secretion in vitro independently of effects on lymphocyte proliferation.
-
CAS Number717824-30-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₀H₁₈FNO₄
-
Molecular Weight355.36
-
Cell PermeableYes
-
Purity>98%
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA novel immunosuppressive drug
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD18633262
-
PubChem CID9820008
-
SMILESCOC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F
-
InChi1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25)
-
InChi KeyXPRDUGXOWVXZLL-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameVidofludimus
-
Alternative nameVidofludimus
-